Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Thrombocytopenia and FLT3[original query] |
---|
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC cancer 2017 Mar 17 (1): 214. Kato Renpei, Kato Yoichiro, Matsuura Tomohiko, Kanehira Mitsugu, Takata Ryo, Obara Wata |
Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. Oncotarget 2018 Mar 9 (18): 14109-14123. Zhang Yuanyuan, Mai Haixing, Guo Gang, Bi Guofang, Hao Guangtao, Li Yuanyuan, Wang Xiaofang, Cheng Longmei, Wang Jing, Dong Ruihua, Liu Zeyuan, Chen Lijun, Qu Hengy |
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. The New England journal of medicine 2019 10 381 (18): 1728-1740. Perl Alexander E, Martinelli Giovanni, Cortes Jorge E, Neubauer Andreas, Berman Ellin, Paolini Stefania, Montesinos Pau, Baer Maria R, Larson Richard A, Ustun Celalettin, Fabbiano Francesco, Erba Harry P, Di Stasi Antonio, Stuart Robert, Olin Rebecca, Kasner Margaret, Ciceri Fabio, Chou Wen-Chien, Podoltsev Nikolai, Recher Christian, Yokoyama Hisayuki, Hosono Naoko, Yoon Sung-Soo, Lee Je-Hwan, Pardee Timothy, Fathi Amir T, Liu Chaofeng, Hasabou Nahla, Liu Xuan, Bahceci Erkut, Levis Mark |
Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia. Clinical lymphoma, myeloma & leukemia 2020 2 20 (3): 156-167. Rasekh Eman O, Elsayed Ghada M, Madney Youssef, El Gammal Mosaad |
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Annals of hematology 2021 Sep . Zhao Peng, Ni Ming, Ma Dan, Fang Qin, Zhang Yan, Li Yanju, Huang Yi, Chen Ying, Chai Xiao, Zhan Yun, Li Yan, Kang Qian, Zhao Mei, Liu Min, Zhang Fengqi, Huang Shisi, Wen Shuangshuang, Deng Bo, Wang Jis |
Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia. Cancer 2022 Oct . Ye Matthew T, Wang Yi, Zuo Zhuang, Calin Steliana, He Hua, Tang Zhenya, Jabbour Elias J, Borthakur Gautam, Zhang Yizhuo, Yang Yaling, You M Jam |
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia. Journal of cancer research and clinical oncology 2022 1 148 (11): 3191-3202. Fleischmann Maximilian, Scholl Sebastian, Frietsch Jochen J, Hilgendorf Inken, Schrenk Karin, Hammersen Jakob, Prims Florian, Thiede Christian, Hochhaus Andreas, Schnetzke U |
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: